Explore 3 Stock Ideas & Industry Insights Download Free Report

Modular Medical Inc

Healthcare US MODD

4.29USD
-0.05(1.15%)

Last update at 2026-06-23T20:00:00Z

Day Range

4.304.87
LowHigh

52 Week Range

0.682.65
LowHigh

Fundamentals

  • Previous Close 4.34
  • Market Cap52.07M
  • Volume77043
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-17.50900M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.53

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -13.87734M -18.63116M -7.37638M -5.31927M -2.53791M
Minority interest - - - - -
Net income -13.87894M -18.63276M -7.37798M -5.32087M -2.53950M
Selling general administrative 4.82M 7.20M 3.25M 2.31M 0.68M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation 0.15M 0.20M 0.18M 0.04M 0.01M
Ebit -13.87831M -14.92640M -7.33671M -5.34802M -2.57730M
Ebitda -13.72494M -14.36056M -7.15474M -5.31259M -2.56283M
Depreciation and amortization 0.15M 0.57M 0.18M 0.04M 0.01M
Non operating income net other - - - - -
Operating income -13.87831M -14.92640M -7.33671M -5.34802M -2.57730M
Other operating expenses 13.88M 14.93M 7.34M 5.35M 2.58M
Interest expense -0.97500M 2.75M 0.04M 0.03M 0.00000M
Tax provision 0.00160M 0.00160M 0.00160M 0.00160M 0.00159M
Interest income - - 0.00013M 0.03M 0.04M
Net interest income 0.00000M -2.75223M -0.03966M 0.03M 0.04M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00160M 0.00160M 0.00160M 0.00160M 0.00159M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 13.88M 14.93M 7.34M 5.35M 2.58M
Cost of revenue - - - - -
Total other income expense net 0.00097M -3.70476M -0.03966M 0.03M 0.04M
Discontinued operations - - - - -
Net income from continuing ops -13.87894M -18.63276M -7.37798M -5.32087M -2.53950M
Net income applicable to common shares -13.87894M -18.63276M -7.37798M -5.32087M -2.53950M
Preferred stock and other adjustments - - - - -
Breakdown 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31
Type yearly yearly yearly yearly yearly
Date 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31
Total assets 13.81M 7.25M 9.85M 2.25M 3.86M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.32M 0.15M 0.00096M 0.00247M 64.16M
Total liab 2.27M 2.17M 1.01M 3.52M 0.98M
Total stockholder equity 11.54M 5.08M 8.84M -1.27515M 2.88M
Deferred long term liab - - - - -
Other current liab 0.28M 338.70M 0.52M 0.50M 0.20M
Common stock 0.03M 0.01M 0.01M 0.02M 0.02M
Capital stock 0.03M 0.01M 0.01M 0.02M 0.02M
Retained earnings -65.92900M -48.45871M -34.57977M -15.94701M -8.56903M
Other liab - - - 0.04M 0.14M
Good will - - - - -
Other assets - - 0.10M 0.10M 0.10M
Cash 9.23M 3.80M 9.08M 1.47M 3.12M
Cash and equivalents - - - - -
Total current liabilities 1.46M 0.98M 0.97M 3.30M 0.66M
Current deferred revenue - -338.35930M - - -
Net debt -8.04200M -2.25413M -8.89156M 1.34M -2.85118M
Short term debt 0.37M 0.36M 0.14M 2.63M 0.09M
Short long term debt - - - 2.50M -
Short long term debt total 1.19M 1.55M 0.18M 2.81M 0.27M
Other stockholder equity 77.43M 53.52M 43.41M 14.65M 11.43M
Property plant equipment - 3.20M 0.36M 0.50M 0.57M
Total current assets 9.70M 4.05M 9.39M 1.65M 3.19M
Long term investments - - - - -
Net tangible assets - 5.08M 8.84M -1.27515M 2.88M
Short term investments - - - - -
Net receivables 0.15M - - - -
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.80M 0.29M 0.30M 0.17M 0.37M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -0.05169M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 0.10M 0.10M 0.10M
Deferred long term asset charges - - - - -
Non current assets total 4.11M 3.20M 0.46M 0.60M 0.67M
Capital lease obligations 1.19M 1.55M 0.18M 0.31M 0.27M
Long term debt total - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -1.63775M -0.05476M -0.10967M -0.26079M -0.07712M
Change to liabilities -0.20076M 0.35M -0.08675M 0.53M 0.16M
Total cashflows from investing activities -1.63775M -0.05476M -0.10967M -0.26079M -0.07712M
Net borrowings - 4.14M 2.58M 2.58M -0.00052M
Total cash from financing activities 7.37M 17.92M 4.36M 0.92M 4.14M
Change to operating activities -0.01438M 0.73M 0.03M -0.14089M 0.00121M
Net income -13.87894M -18.63276M -7.37798M -5.32087M -2.53950M
Change in cash -5.27705M 7.61M -1.65367M -3.43163M 2.26M
Begin period cash flow 9.08M 1.47M 3.12M 6.55M 4.30M
End period cash flow 3.80M 9.08M 1.47M 3.12M 6.55M
Total cash from operating activities -11.01164M -10.25953M -5.90866M -4.09484M -1.80793M
Issuance of capital stock 7.37M 13.79M 1.79M 0.92M 4.14M
Depreciation 0.15M 0.20M 0.18M 0.04M 0.01M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities -1.63775M 6.24M 2.58M -0.26079M -0.00052M
Change to netincome 2.73M 5.26M 1.34M 0.80M 0.55M
Capital expenditures 1.64M 0.05M 0.11M 0.26M 0.08M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.21182M 0.42M -0.06115M 0.39M 0.17M
Stock based compensation 2.72M 4.03M 1.23M 0.80M 0.53M
Other non cash items 0.20M 3.72M 0.12M 4.25M 0.02M
Free cash flow -12.64940M -10.31429M -6.01833M -4.35563M -1.88506M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
MODD
Modular Medical Inc
-0.05 1.15% 4.29 - - - 5.07 -3.2145
ABT
Abbott Laboratories
2.70 3.07% 90.53 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation
5.31 1.74% 310.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC
1.36 1.72% 80.63 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp
1.27 2.86% 45.60 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

Profile

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

Modular Medical Inc

10740 Thornmint Road, San Diego, CA, United States, 92127

Key Executives

Name Title Year Born
Mr. Paul M. DiPerna Founder, Pres, CFO, Sec., Treasurer & Chairman 1959
Mr. James E. Besser Chief Exec. Officer 1976
Mr. Kevin Schmid Chief Operating Officer 1959
Marc Goldman Head of Engineering NA
Mr. Paul M. DiPerna Founder, Chairman, President, CFO & Treasurer 1959
Mr. James E. Besser Chief Executive Officer 1976
Mr. James E. Besser Chief Executive Officer 1977

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.